Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Levy

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Personality and Social Psychology|November 3, 2015
I don't want the money, I just want your time: How moral identity overcomes the aversion to giving time to prosocial causesAmericus Reed, Adam Kay, Stephanie Finnel, et al.
Cancer Informatics|November 14, 2014
Prediction of MicroRNA Precursors Using Parsimonious Feature SetsPetra Stepanowsky, Eric Levy, Jihoon Kim, et al.
La Revue Du Praticien|January 6, 2005
[Ovarian cancer: diagnosis of early stages, referral of patients and management]Fabrice Lécuru, Ulrike Metzger, Eric Levy, et al.
Nuclear Medicine Communications|November 3, 2005
FDG PET in patients with cancer of an unknown primaryHélène Kolesnikov-Gauthier, Eric Levy, Pascal Merlet, et al.
Scientific Reports|July 26, 2016
Immune DNA signature of T-cell infiltration in breast tumor exomesEric Levy, Rachel Marty, Valentina Gárate Calderón, et al.
The Prostate|August 21, 2007
Serum PSA half-life as a predictor of survival for hormone-refractory prostate cancer patients: modelization using a standardized set of response criteriaEugeniu Banu, Adela Banu, Jacques Medioni, et al.
BJU International|February 13, 2009
What is the real impact of bone pain on survival in patients with metastatic hormone-refractory prostate cancer treated with docetaxel?Stéphane Oudard, Eugeniu Banu, Jacques Medioni, et al.
Annals of Surgical Oncology|March 29, 2021
Oncological Safety of Oncoplastic Level II Mammoplasties After Neoadjuvant Chemotherapy for Large Breast Cancers: A Matched-Cohort AnalysisRaquel F D van la Parra, Krishna B Clough, Helene H Thygesen, et al.
Bioinformatics (Oxford, England)|June 8, 2014
MAGI: a Node.js web service for fast microRNA-Seq analysis in a GPU infrastructureJihoon Kim, Eric Levy, Alex Ferbrache, et al.
Gynecologic Oncology|March 22, 2003
Epirubicin and paclitaxel (EPI-TAX regimen) for advanced ovarian cancer after failure of platinum-containing regimensIsabelle Ray-Coquard, Thomas Bachelot, Jean-Paul Guastalla, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Personality and Social Psychology|November 3, 2015
I don't want the money, I just want your time: How moral identity overcomes the aversion to giving time to prosocial causesAmericus Reed, Adam Kay, Stephanie Finnel, et al.
Cancer Informatics|November 14, 2014
Prediction of MicroRNA Precursors Using Parsimonious Feature SetsPetra Stepanowsky, Eric Levy, Jihoon Kim, et al.
La Revue Du Praticien|January 6, 2005
[Ovarian cancer: diagnosis of early stages, referral of patients and management]Fabrice Lécuru, Ulrike Metzger, Eric Levy, et al.
Nuclear Medicine Communications|November 3, 2005
FDG PET in patients with cancer of an unknown primaryHélène Kolesnikov-Gauthier, Eric Levy, Pascal Merlet, et al.
Scientific Reports|July 26, 2016
Immune DNA signature of T-cell infiltration in breast tumor exomesEric Levy, Rachel Marty, Valentina Gárate Calderón, et al.
The Prostate|August 21, 2007
Serum PSA half-life as a predictor of survival for hormone-refractory prostate cancer patients: modelization using a standardized set of response criteriaEugeniu Banu, Adela Banu, Jacques Medioni, et al.
BJU International|February 13, 2009
What is the real impact of bone pain on survival in patients with metastatic hormone-refractory prostate cancer treated with docetaxel?Stéphane Oudard, Eugeniu Banu, Jacques Medioni, et al.
Annals of Surgical Oncology|March 29, 2021
Oncological Safety of Oncoplastic Level II Mammoplasties After Neoadjuvant Chemotherapy for Large Breast Cancers: A Matched-Cohort AnalysisRaquel F D van la Parra, Krishna B Clough, Helene H Thygesen, et al.
Bioinformatics (Oxford, England)|June 8, 2014
MAGI: a Node.js web service for fast microRNA-Seq analysis in a GPU infrastructureJihoon Kim, Eric Levy, Alex Ferbrache, et al.
Gynecologic Oncology|March 22, 2003
Epirubicin and paclitaxel (EPI-TAX regimen) for advanced ovarian cancer after failure of platinum-containing regimensIsabelle Ray-Coquard, Thomas Bachelot, Jean-Paul Guastalla, et al.
Pageof 2